Operating

Other Non-cash Income and Expense

Kailera Therapeutics Other Non-cash Income and Expense increased by 171.4% to $19.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: orcl_other_noncash_income_expense

Historical Data

2 periods
 Q1 '25Q1 '26
Value$7.00K$19.00K
QoQ Change—+171.4%
YoY Change—+171.4%
Range$7.00K – $19.00K
Avg YoY Growth+171.4%
Median YoY Growth+171.4%

Frequently Asked Questions

What is Kailera Therapeutics 's other non-cash income and expense?
Kailera Therapeutics (KLRA) reported other non-cash income and expense of $19.00K in Q1 2026.